Trial NCT00668564

View at ClinicalTrials.gov 
Org. Study IDs: MT2008-02
Secondary IDs: 0801M25202

Last trial update was posted on 2017-12-28

MeSH Interventions

Alemtuzumab Busulfan Cyclophosphamide

MeSH Conditions

Aphasia, Primary Progressive Aspartylglucosaminuria Frontotemporal Dementia Fucosidosis Leukodystrophy, Globoid Cell Mannosidase Deficiency Diseases Metabolism, Inborn Errors Mucopolysaccharidosis I Mucopolysaccharidosis VI Mucopolysaccharidosis VII Niemann-Pick Disease, Type A Niemann-Pick Disease, Type B Niemann-Pick Disease, Type C Niemann-Pick Diseases Pick Disease of the Brain Sphingolipidoses Syndrome Wolman Disease alpha-Mannosidosis

Other Conditions

Alpha Mannosidosis Hurler's Syndrome Krabbe Disease Maroteaux-Lamy Syndrome Niemann-Pick Disease Type B Sly Syndrome Wolman's Disease

Stopping Reasons

Replaced by another study

Limitations And Caveats

Other secondary objectives outlined in study protocol were not analyzed; number of patients were too few to be relevant.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID